Baseline characteristics
| Characteristic | HERO-1 | CTFC substudy |
|---|---|---|
| Number | 412 | 251 |
| Age (years) (mean (SD)) | 61.4 (11.9) | 60.8 (11.4) |
| Female (%) | 25 | 24 |
| Height (cm) (mean (SD)) | 134.1 (50.6) | 140.7 (48.1) |
| Weight (kg) (mean (SD)) | 82.0 (26.4) | 81.7 (25.9) |
| Heart rate (beats/min) (mean (SD)) | 75.2 (17.1) | 74.8 (16.0) |
| Diastolic blood pressure (mm Hg) (mean (SD)) | 132.0 (21.3) | 133.5 (21.0) |
| Previous infarction (%) | 14 | 11 |
| Previous PTCA (%) | 4 | 4 |
| Previous CABG (%) | 3 | 2 |
| Hypertension (%) | 30 | 27 |
| Smoking (%) | 63 | 65 |
| Duration of streptokinase infusion (min) (mean (SD)) | 49.7 (16.4) | 48.5 (16.9) |
| Hirulog treatment (%) | 66 | 69 |
| TIMI 3 flow at 90 minutes (%) | 43.0 | 42.5 |
| Time to treatment (hours) (mean (SD)) | 3.94 (2.7) | 4.01 (2.7) |
CABG, coronary artery bypass graft; CTFC, corrected TIMI frame count; PTCA, percutaneous transluminal coronary angioplasty; TIMI, thrombolysis in myocardial infarction trial.